Logo

TGen's Drug Development Group to Use Mission3 Product-Lifecycle Software

Aug 15, 2007
NEW YORK (GenomeWeb News) - The Translational Genomics Research Institute’s TD2 drug-development arm has agreed to use product-lifecycle software from Mission3, the organizations said recently.
 
TD2 will use the company’s MissionFire and FastCrossing software to help manage its drug development process.
 
FastCrossing is a graphical, web-based tool used in application submissions, while MissionFire is used in document and project management.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.